News & Media

Alzheimer’s: Delhi pharma company gets Bengaluru scientists’ drug candidate
January 5, 2023
Hamsa Biopharma, which will take the drug — Christened TGR63 — to trials through its parent company in the US, IGC Pharma, hopes it can eventually be made available in the market.

Scientists discover possible drug target for Alzheimer’s
December 20, 2022
Researchers in India say they have discovered a promising drug target that may slow or even halt the progression of Alzheimer’s.
